1. Home
  2. NX vs BBNX Comparison

NX vs BBNX Comparison

Compare NX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

N/A

Current Price

$19.20

Market Cap

870.7M

Sector

Industrials

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$18.87

Market Cap

997.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NX
BBNX
Founded
1927
2015
Country
United States
United States
Employees
7071
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.7M
997.9M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
NX
BBNX
Price
$19.20
$18.87
Analyst Decision
Strong Buy
Buy
Analyst Count
2
13
Target Price
★ $26.00
$23.28
AVG Volume (30 Days)
459.8K
★ 1.3M
Earning Date
09-03-2026
10-27-2026
Dividend Yield
★ 1.70%
N/A
EPS Growth
N/A
★ 78.95
EPS
★ 0.57
N/A
Revenue
★ $1,837,641,000.00
$100,251,000.00
Revenue This Year
$1.98
$25.74
Revenue Next Year
$0.51
$44.51
P/E Ratio
$33.51
★ N/A
Revenue Growth
43.81
★ 53.94
52 Week Low
$11.04
$8.80
52 Week High
$23.33
$32.71

Technical Indicators

Market Signals
Indicator
NX
BBNX
Relative Strength Index (RSI) 41.16 45.45
Support Level $18.30 $15.76
Resistance Level $19.62 $20.48
Average True Range (ATR) 0.73 1.65
MACD -0.23 -0.33
Stochastic Oscillator 6.31 42.11

Price Performance

Historical Comparison
NX
BBNX

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: